Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03824509 · ClinicalTrials.gov registry record

Echocardiographic Risk Factors of Stroke in Patients With Atrial Fibrillation

A clinical trial, sponsored by MaineHealth.

Completed
Registry status
140
Enrollment target

NCT03824509 is a clinical trial that has completed, run by MaineHealth. The registered enrollment target is 140 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03824509 has completed, sponsored by MaineHealth.

COMPLETED
Registry status
140 participants
Enrollment target

Study Summary

The goal is to review patients with known atrial fibrillation who suffered a stroke or transient ischemic attack (TIA) to incorporate any structural heart abnormalities into the overall clinical picture. A better understanding of the additional risk of a stroke or TIA in patients with specific structural abnormalities may be beneficial in guiding future treatment decisions.

Interventions

  • OTHER Chart Review

Trial Details

FieldValue
Enrollment Target 140 participants
Start Date 2019-01-01
Est. Completion 2020-05-21

Sponsor

MaineHealth

26 total trials

What the Registry Record Tells You About NCT03824509

The ClinicalTrials.gov registry entry for NCT03824509 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MaineHealth, which has 26 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Chart Review is the first listed.

NCT03824509 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03824509 about?

NCT03824509 is a clinical study titled "Echocardiographic Risk Factors of Stroke in Patients With Atrial Fibrillation". The goal is to review patients with known atrial fibrillation who suffered a stroke or transient ischemic attack (TIA) to incorporate any structural heart abnormalities into the overall clinical picture. A better understanding of the additional risk of a stroke or TIA in patients with specific struc...

What is the current status of trial NCT03824509?

This trial is currently completed. The enrollment target is 140 participants. The study started on 2019-01-01. Estimated completion is 2020-05-21.

What interventions are being tested in trial NCT03824509?

The interventions under investigation include: Chart Review (OTHER).

Who is sponsoring clinical trial NCT03824509?

This trial is sponsored by MaineHealth, which has 26 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.